Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of <sup>225</sup>Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

MD2 mediates COPD pathogenesis by inducing airway inflammation and ferroptosis through the TLR4/MyD88 pathway.

Biochimica et biophysica acta. Molecular basis of disease·2025
Same author

NRBF2 homodimerization by its coiled-coil domain strengthens association with the PtdIns3K complex mediated by the MIT domain to promote autophagy.

Autophagy·2025
Same author

A Cascade Approach to Valorizing <i>Camellia oleifera</i> Abel Shell: Ultrasound-Assisted Extraction Coupled with Resin Purification for High-Efficiency Production of Multifunctional Polyphenols.

Antioxidants (Basel, Switzerland)·2025
Same author

Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study.

Drugs - real world outcomes·2025
Same author

Development and validation of the mental internal friction scale (MIFS) for chinese college students.

BMC psychology·2025

Related Experiment Video

Updated: Jun 6, 2026

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging

Published on: November 20, 2018

Inorganic nanoparticle-based contrast agents for molecular imaging.

Eun Chul Cho1, Charles Glaus, Jingyi Chen

  • 1Department of Biomedical Engineering, Washington University, St. Louis, Missouri 63130, USA.

Trends in Molecular Medicine
|November 16, 2010
PubMed
Summary

Inorganic nanoparticles (NPs), such as quantum dots (QDs), iron oxide, and gold, are advanced contrast agents for molecular imaging. Their tunable properties and targeting capabilities offer superior diagnostics for future clinical use.

More Related Videos

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
13:21

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

Related Experiment Videos

Last Updated: Jun 6, 2026

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging

Published on: November 20, 2018

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
13:21

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

Published on: July 21, 2011

Area of Science:

  • Nanotechnology and Materials Science
  • Biomedical Imaging and Diagnostics

Background:

  • Traditional contrast agents have limitations in sensitivity and specificity.
  • Inorganic nanoparticles (NPs) offer tunable optical and magnetic properties for enhanced imaging.
  • Semiconductor quantum dots (QDs), iron oxide NPs, and gold NPs are key examples.

Purpose of the Study:

  • To review recent advancements in inorganic NP-based contrast agents for molecular imaging.
  • To discuss critical aspects including contrast enhancement, surface modification, and targeting.
  • To examine NP clearance and toxicity for safe clinical translation.

Main Methods:

  • Review of current literature on inorganic nanoparticle contrast agents.
  • Analysis of NP properties: composition, structure, size, and shape engineering.
  • Evaluation of surface modification strategies for biomarker targeting.

Main Results:

  • Inorganic NPs provide significant contrast enhancement, equivalent to millions of molecular counterparts.
  • Surface modification allows for specific tissue targeting of disease biomarkers.
  • Multimodal imaging capabilities can be integrated into single NP platforms.

Conclusions:

  • Inorganic NPs represent a promising class of contrast agents for molecular imaging.
  • Continued research is focused on developing highly sensitive, target-specific, and safe agents.
  • Clinical applications of these advanced inorganic NP contrast agents are anticipated in the near future.